Analysis of Turkish market in ICC life sciences arbitration

In an ICC dispute, CRA was retained by respondent to assess the damages due to the termination of as distribution agreement for pharmaceuticals in Turkey.  CRA analyzed the Turkish market, including pricing and reimbursement issues, to determine the profits lost as a result of the early termination of the distribution agreement

Meet Our Team